RMI Nuclear Justice Documents

Table 4 (cont'd) Patient No. & sex Age at surgery Years post exposure Pathologic diagnosis Remarks Utirik exposed 2229 F 32 2208 F — 33 2212 F 53 15 1/2 Follicular carcinoma 19 Adenomatous nodules 19 Adenomatous nodules with Hiirthle cell adenoma Divided opinion: atypical adenoma Hyperplasia 2221 F 73 19 Adenomatous nodules with follicular Hyperplasia, focal atypla 2160 F 2150 M 2194 F 2261x M 2236 M 2193 F 25 34 59 50 35 56 21 1/2 22 22 23 1/2 24 25 1/2 Papillary carcinoma Follicular adenoma Papillary carcinoma No diagnostic lesion Follicular adenoma Adenomatous nodules Hyperplasia 58 25 1/2 Adenomatous nodules with occult papillary carcinoma 2195 F 2215 F 2147 F 49 30 25 1/2 25 1/2 2196 F 63 26 1/2 2132 F 28 27 2239 F 29 27 adenoma Adenomatous nodule Adenomatous nodules Adenomatous nodules Adenomatous nodules Lymph node metastases Focal hyperplasia Papillary hyperplasia Diffuse Adenomatous nodule Fibrosis Adenomatous nodule Adenomatous nodule Papillary hyperplasia 1007 1573 867 4023 1556 yim sz = 938 829 841 rr] fj My Rongelap unexposed controls 33 41 41 66 28 50 44 34 Adenomatous nodules with occult papillary carcinoma . Fibrosis, hyperplasia Papillary carcinoma Papillary carcinoma Adenomatous nodule Fibrosis Adenomatous nodule Papillary hyperplasia No diagnostic lesion - 65 -